- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MOBIA MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | Mobia Medical appoints Reza Zadno to board of directors | 1 | Investing.com | ||
| Mi | Mobia Medical beruft Medizintechnik-Veteranen Reza Zadno in den Verwaltungsrat | 3 | Investing.com Deutsch | ||
| Mi | Mobia Medical, Inc.: Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors | 86 | GlobeNewswire (Europe) | AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor... ► Artikel lesen | |
| Mi | Mobia Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Mobia Medical reports two-year stroke therapy data in Neurology | 1 | Investing.com | ||
| Di | Mobia Medical, Inc.: Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim Paired VNS Therapy | 1 | GlobeNewswire (USA) | ||
| 02.07. | Mobia Medical: CMS schlägt stabilen Vergütungssatz für Vivistim-Verfahren vor | 1 | Investing.com Deutsch | ||
| 02.07. | Mobia Medical, Inc.: Mobia Medical Announces Vivistim Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule | 1 | GlobeNewswire (USA) | ||
| 04.06. | Mobia Medical, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 02.06. | BTIG initiates Mobia Medical stock coverage with buy rating | 1 | Investing.com | ||
| 02.06. | Wolfe Research initiates Mobia Medical stock with outperform rating | 1 | Investing.com | ||
| 02.06. | JPMorgan initiates Mobia Medical stock with Overweight rating | 1 | Investing.com | ||
| 02.06. | Goldman Sachs initiates Mobia Medical stock with buy rating on neuro tech | 2 | Investing.com | ||
| 02.06. | Mobia Medical: Goldman Sachs startet Coverage mit Kaufempfehlung dank Neurotechnologie | 5 | Investing.com Deutsch | ||
| 11.05. | Mobia Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Mobia Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 08.05. | Health stocks Odyssey, Mobia Medical disappoint on first day of trading | 1 | Seeking Alpha | ||
| 08.05. | MedTech firm Mobia Medical prices $150M IPO | 2 | Seeking Alpha | ||
| 08.05. | Nerve stimulation device maker Mobia Medical prices IPO at $15, the midpoint of the range | 2 | Renaissance Capital | ||
| 08.05. | Mobia Medical Prices $150 Mln Share IPO | 540 | AFX News | WASHINGTON (dpa-AFX) - Mobia Medical, Inc. (MOBI), on Friday announced that it has priced its initial public offering of 10 million common shares at $15.00 each.The medical device company expects... ► Artikel lesen |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,439 | +2,81 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,740 | -1,28 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,610 | -10,06 % | Celsion Bank wird Mitglied des Liechtensteinischen Bankenverbandes | Vaduz - Die Celsion Bank AG ist seit 1. Juli 2026 Vollmitglied des Liechtensteinischen Bankenverbandes (LBV). Die Celsion Bank bringt ein klares Profil mit Fokus auf digitale Vermögenswerte ein und... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 44,200 | -0,90 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| INSPIREMD | 0,545 | 0,00 % | InspireMD Inc.: InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,389 | +1,36 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,928 | 0,00 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,750 | +3,60 % | Inogen appoints Andy Reding as chief operating officer | ||
| INTELLIGENT BIO SOLUTIONS | 2,230 | +1,36 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,559 | 0,00 % | Lexaria Bioscience Corp. - 10-Q, Quarterly Report | ||
| INCANNEX HEALTHCARE | 3,135 | -0,48 % | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| GLUCOTRACK | 0,500 | 0,00 % | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| LENSAR | 5,680 | +0,18 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| HEARTBEAM | 0,575 | -0,12 % | HeartBeam receives patent for multi-modal cardiac sensing device | ||
| JIN MEDICAL INTERNATIONAL | 1,900 | 0,00 % | Jin Medical International Ltd. - 6-K, Report of foreign issuer |
Das Unternehmen MOBIA MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,050 (+0,42 %) liegt der Kurs bei 12,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOBIA MEDICAL INC finden Sie auf Wallstreet Online.